CD8+ T cells appear to play a role in the recognition of these immunogenic neopeptides; in fact, CD8+ T cell infiltrates are present in LS-CRC, notably and abundantly in cancer nests, with infiltration suggested to be associated with improved prognoses in LS [26, 43, 44]. This evidence concerns the gene CD8A and Leigh syndrome.